Table 5.

Median adherence in subgroups of patients treated with r-hGH alone or with r-hGH plus other hormonal replacement therapy during a 1-year follow up.

Follow up	Population	Median adherence rates
Between V0 and V1	r-h GH alone	88%
	r-h GH plus other*	75%
Between V1 and V2	r-h GH alone	83%
	r-h GH plus other*	76%
Between V0 and V2	r-h GH alone	84%
	r-h GH plus other*	75%

^*These therapies include levothyroxine treatment for secondary hypothyroidism, hydrocortisone treatment for secondary hypoadrenalism, gonadal steroids (testosterone undecanoate or estroprogestinic therapy) for secondary hypogonadism; finally, desmopressin for diabetes insipidus.